Gemina Laboratories Ltd. (CSE:GLAB)
Canada flag Canada · Delayed Price · Currency is CAD
0.8500
-0.1200 (-12.37%)
Jun 4, 2025, 1:17 PM EDT

Gemina Laboratories Cash Flow Statement

Millions CAD. Fiscal year is Feb - Jan.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Jan '25 Jan '24 Jan '23 Jan '22 Jan '21
Net Income
-4.07-5.22-5.98-4.73-1.11
Depreciation & Amortization
0.110.090.050.040.02
Stock-Based Compensation
0.520.570.390.7-
Other Operating Activities
0.140.050.0100.48
Change in Accounts Receivable
00.35-0.2-0.17-0.01
Change in Accounts Payable
2.030.851.280.310.2
Change in Other Net Operating Assets
-0.040.07-0.06-0.02-0.01
Operating Cash Flow
-1.3-3.24-4.51-3.87-0.43
Capital Expenditures
--0.04-0.08-0.01-
Sale of Property, Plant & Equipment
0.02----
Cash Acquisitions
----0.04
Investment in Securities
---0.43--
Other Investing Activities
--00.02-0.03
Investing Cash Flow
0.02-0.04-0.510.010.02
Short-Term Debt Issued
-0.2---
Long-Term Debt Issued
0.91----
Total Debt Issued
0.910.2---
Long-Term Debt Repaid
-0.12-0.09-0.06-0.07-
Net Debt Issued (Repaid)
0.790.11-0.06-0.07-
Issuance of Common Stock
0.523.24.62.793.63
Other Financing Activities
-0.03-0.11-0.591.42-2.05
Financing Cash Flow
1.283.23.944.141.58
Net Cash Flow
-0-0.08-1.070.271.18
Free Cash Flow
-1.3-3.29-4.59-3.88-0.43
Free Cash Flow Per Share
-0.02-0.04-0.08-0.08-0.01
Levered Free Cash Flow
-0.4-1.41-2.35-2.72-
Unlevered Free Cash Flow
-0.3-1.39-2.35-2.72-
Change in Net Working Capital
-2.03-1.24-1.020.5-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.